Synthesis and evaluation of ethyleneoxylated and allyloxylated chalcone derivatives for imaging of amyloid β plaques by SPECT
摘要:
We report radioiodinated chalcone derivatives as new SPECT imaging probes for amyloid beta (A beta) plaques. The monoethyleneoxy derivative 2 and allyloxy derivative 8 showed a high affinity for A beta(1-42) aggregates with K-i values of 24 and 4.5 nM, respectively. Fluorescent imaging demonstrated that 2 and 8 clearly stained thioflavin-S positive A beta plaques in the brain sections of Tg2576 transgenic mice. In vitro autoradiography revealed that [I-125]2 displayed no clear accumulation toward A beta plaques in the brain sections of Tg2576 mice, whereas the accumulation pattern of [I-125]8 matched with the presence of A beta plaques both in the brain sections of Tg2576 mice and an AD patient. In biodistribution studies using normal mice, [I-125]2 showed preferable in vivo pharmacokinetics (4.82%ID/g at 2 min and 0.45%ID/g at 60 min), while [I-125]8 showed only a modest brain uptake (1.62%ID/g at 2 min) with slow clearance (0.56%ID/g at 60 min). [I-125]8 showed prospective binding properties for A beta plaques, although further structural modifications are needed to improve the blood brain barrier permeability and washout from brain. (C) 2014 Elsevier Ltd. All rights reserved.
Synthesis and evaluation of ethyleneoxylated and allyloxylated chalcone derivatives for imaging of amyloid β plaques by SPECT
摘要:
We report radioiodinated chalcone derivatives as new SPECT imaging probes for amyloid beta (A beta) plaques. The monoethyleneoxy derivative 2 and allyloxy derivative 8 showed a high affinity for A beta(1-42) aggregates with K-i values of 24 and 4.5 nM, respectively. Fluorescent imaging demonstrated that 2 and 8 clearly stained thioflavin-S positive A beta plaques in the brain sections of Tg2576 transgenic mice. In vitro autoradiography revealed that [I-125]2 displayed no clear accumulation toward A beta plaques in the brain sections of Tg2576 mice, whereas the accumulation pattern of [I-125]8 matched with the presence of A beta plaques both in the brain sections of Tg2576 mice and an AD patient. In biodistribution studies using normal mice, [I-125]2 showed preferable in vivo pharmacokinetics (4.82%ID/g at 2 min and 0.45%ID/g at 60 min), while [I-125]8 showed only a modest brain uptake (1.62%ID/g at 2 min) with slow clearance (0.56%ID/g at 60 min). [I-125]8 showed prospective binding properties for A beta plaques, although further structural modifications are needed to improve the blood brain barrier permeability and washout from brain. (C) 2014 Elsevier Ltd. All rights reserved.